Vaxart, Inc. (NASDAQ:VXRT), a biotechnology company specializing in the development of oral recombinant vaccines with a market capitalization of approximately $159 million, announced on Monday an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback